SE8505527L - Preparat for forbettring av den cellulera metabolismen - Google Patents

Preparat for forbettring av den cellulera metabolismen

Info

Publication number
SE8505527L
SE8505527L SE8505527A SE8505527A SE8505527L SE 8505527 L SE8505527 L SE 8505527L SE 8505527 A SE8505527 A SE 8505527A SE 8505527 A SE8505527 A SE 8505527A SE 8505527 L SE8505527 L SE 8505527L
Authority
SE
Sweden
Prior art keywords
mmol
composition
conditions
cellular metabolism
overweight
Prior art date
Application number
SE8505527A
Other languages
Unknown language ( )
English (en)
Other versions
SE8505527D0 (sv
SE468074B (sv
Inventor
N C Henningsen
S Jaedig
Original Assignee
Prevent Fa
Medina Hb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevent Fa, Medina Hb filed Critical Prevent Fa
Priority to SE8505527A priority Critical patent/SE468074B/sv
Publication of SE8505527D0 publication Critical patent/SE8505527D0/sv
Priority to AU65133/86A priority patent/AU592385B2/en
Priority to AT86850396T priority patent/ATE74760T1/de
Priority to EP86850396A priority patent/EP0223762B1/en
Priority to DE198686850396T priority patent/DE223762T1/de
Priority to DE8686850396T priority patent/DE3684882D1/de
Priority to JP61273068A priority patent/JPH07100660B2/ja
Priority to FI864749A priority patent/FI864749A/fi
Priority to NO864682A priority patent/NO175845C/no
Priority to DK560286A priority patent/DK164200C/da
Priority to CA000523514A priority patent/CA1275927C/en
Publication of SE8505527L publication Critical patent/SE8505527L/sv
Publication of SE468074B publication Critical patent/SE468074B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Special Wing (AREA)
  • Seasonings (AREA)
  • Detergent Compositions (AREA)
  • Saccharide Compounds (AREA)
SE8505527A 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen SE468074B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8505527A SE468074B (sv) 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen
AU65133/86A AU592385B2 (en) 1985-11-22 1986-11-14 Composition to improve cellular metabolism
JP61273068A JPH07100660B2 (ja) 1985-11-22 1986-11-18 細胞代謝を向上させる組成物
DE198686850396T DE223762T1 (de) 1985-11-22 1986-11-18 Zusammensetzung fuer den zellstoffwechsel.
EP86850396A EP0223762B1 (en) 1985-11-22 1986-11-18 Use of a composition for the manufacture of a medicament for the improvement of cellular metabolism
AT86850396T ATE74760T1 (de) 1985-11-22 1986-11-18 Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels.
DE8686850396T DE3684882D1 (de) 1985-11-22 1986-11-18 Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels.
FI864749A FI864749A (fi) 1985-11-22 1986-11-21 Preparat foer foerbaettring av den cellulaera metabolismen.
NO864682A NO175845C (no) 1985-11-22 1986-11-21 Anvendelse av kalium-, magnesium- og fosfationer i slankepreparat
DK560286A DK164200C (da) 1985-11-22 1986-11-21 Praeparat til forbedring af den cellulaere metabolisme
CA000523514A CA1275927C (en) 1985-11-22 1986-11-21 Composition to improve cellular metabolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505527A SE468074B (sv) 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen

Publications (3)

Publication Number Publication Date
SE8505527D0 SE8505527D0 (sv) 1985-11-22
SE8505527L true SE8505527L (sv) 1987-05-23
SE468074B SE468074B (sv) 1992-11-02

Family

ID=20362216

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8505527A SE468074B (sv) 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen

Country Status (10)

Country Link
EP (1) EP0223762B1 (sv)
JP (1) JPH07100660B2 (sv)
AT (1) ATE74760T1 (sv)
AU (1) AU592385B2 (sv)
CA (1) CA1275927C (sv)
DE (2) DE3684882D1 (sv)
DK (1) DK164200C (sv)
FI (1) FI864749A (sv)
NO (1) NO175845C (sv)
SE (1) SE468074B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207800B (en) * 1990-05-10 1993-06-28 Andras Sikter Process for producing composition for improving condition and for treating different illnesses
US5639471A (en) * 1995-06-06 1997-06-17 Campbell Soup Company Method for determining diet program effectiveness
DE19925483A1 (de) * 1998-06-04 2000-02-03 Ludwig Schwebel Wirkstoff zur Behandlung der Zuckerkrankheit
GB9819530D0 (en) 1998-09-09 1998-10-28 Smithkline Beecham Plc Novel compositions and use
US9585827B2 (en) * 2000-01-21 2017-03-07 The Procter & Gamble Company Kits comprising a beverage composition and information for use
CN102949413B (zh) * 2012-06-08 2014-12-03 辽宁海思科制药有限公司 一种转化糖电解质注射液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ182117A (en) * 1975-09-23 1978-07-28 Johnson & Johnson Electrolyte drink osmolality 80 to 200 mosm per litre
US4322407A (en) * 1978-12-11 1982-03-30 Vitapharm Pharmaceutical Pty. Ltd. Electrolyte drink

Also Published As

Publication number Publication date
AU6513386A (en) 1987-05-28
ATE74760T1 (de) 1992-05-15
DE3684882D1 (de) 1992-05-21
DK164200B (da) 1992-05-25
DK560286A (da) 1987-05-23
NO175845C (no) 1994-12-21
FI864749A (fi) 1987-05-23
DK560286D0 (da) 1986-11-21
DE223762T1 (de) 1987-10-15
JPH07100660B2 (ja) 1995-11-01
EP0223762B1 (en) 1992-04-15
CA1275927C (en) 1990-11-06
SE8505527D0 (sv) 1985-11-22
NO175845B (sv) 1994-09-12
SE468074B (sv) 1992-11-02
FI864749A0 (fi) 1986-11-21
EP0223762A1 (en) 1987-05-27
NO864682L (no) 1987-05-25
DK164200C (da) 1992-10-19
JPS62171654A (ja) 1987-07-28
NO864682D0 (no) 1986-11-21
AU592385B2 (en) 1990-01-11

Similar Documents

Publication Publication Date Title
Bleiler et al. Creatinine excretion: variability and relationships to diet and body size
Stanko et al. Body composition, energy utilization, and nitrogen metabolism with a severely restricted diet supplemented with dihydroxyacetone and pyruvate
DE3856435D1 (de) Verwendung von Gallsäure-aktiviertem Lipase als Diätsupplement
Dowdy et al. Copper-molybdenum interaction in sheep and chicks
DE3677804D1 (de) Therapeutische verwendung von zinnmesoporphyrin.
Matzkies et al. The uricosuric action of protein in man
SE8505527D0 (sv) Preparat for forbettring av den cellulera metabolismen
Herndon et al. Protein requirements in chronic renal insufficient patients: A study of the nitrogen minimum
Kagan et al. The effect of burn wound size on ureagenesis and nitrogen balance.
McArdle Metabolic myopathies: the glycogenoses affecting muscle, and hypo-and hyperkalemic periodic paralysis
Paschke et al. Morquio disease, type B: Activation of GM1-β-galactosidase by GM1-activator protein
Briscoe et al. Diurnal variations in calcium and magnesium excretion in man
Reed et al. Nutritional status and dietary management of elderly diabetic patients
Dole et al. Dietary treatment of hypertension. III. The effect of protein on appetite and weight
Consolazio et al. Dietary carbohydrate and work capacity
Song et al. Pantothenic acid status of pregnant and lactating women
HARO et al. Fasting in obesity: thiamine depletion as measured by erythrocyte transketolase changes
Craig JR Observations on epinephrine and glucagon-induced glycogenolysis and potassium loss in the isolated perfused frog liver
Mansell et al. Reversal of a skeletal myopathy with selenium supplementation in a patient on home parenteral nutrition
Cohn et al. Effects of caloric intake and feeding frequency on carbohydrate metabolism of the rat
TAKEKURA et al. Acute exhaustive exercise changes the metabolic profiles in slow and fast muscles of rat
Yamaguchi et al. A mixture of nucleosides and a nucleotide alters hepatic energy metabolism 24 hours after hepatectomy in rabbits
Chen et al. Zinc attenuation of GDP binding to brown adipocytes mitochondria in genetically obese (ob/ob) mice
Percival et al. Interaction between methionine, fat and choline in the young rat
Pellegrino et al. Increase of muscle permeability to aldolase in several experimental atrophies

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8505527-5